Blog

The graduating class of the inaugural CancerX Accelerator cohort by Moffitt Cancer Center

Photo from Corinne Leach/LinkedIn

Aug 11, 2024, 05:55

The graduating class of the inaugural CancerX Accelerator cohort by Moffitt Cancer Center

Corinne Leach, Acting Director of Digital Innovation Research and Services at Moffitt Cancer Center, shared a post on LinkedIn:

“Congratulations to the graduating class of the inaugural CancerX Accelerator cohort and champions who have worked tirelessly over the last several months to make this brand new program a success in meaningful ways to the startups selected.

3 startups had pilots contracted during this first accelerator by Moffitt Cancer Center! Cancer Insights, Navya Care and a 3rd soon to be announced.

Creating this level of value in an accelerator requires:

focus
leadership alignment on prioritization of problems to be solved and resource allocations
people who remind us always of not only a need to keep patients at the forefront of every product but HOW to do that in ways that actually provide value
clinical operations staff who educate all on what problems are most pressing
streamlined POC and pilot processes in health systems
skilled matchmaking by internal clinical and research champions – the right people to the right startup opportunity

CancerX Accelerator by the numbers:

12 BIPOC founded companies
8 female/non-binary founded companies
12% program acceptance rate
8+ agreements signed
2+ investments underway
4+ months of structured curriculum
70+ mentor connections facilitated

Stay in the loop for the 2025 Cohort!”

The graduating class of the inaugural CancerX Accelerator cohort by Moffitt Cancer Center

Source: Corinne Leach/LinkedIn

More posts about CancerX Accelerator in OncoDaily.

Alexandra Grace Andrea Brian Gonzalez cancer Cancer Insights CancerX CancerX Accelerator Cordovano Corinne Leach Kamal Jethwani Lindsay Deneault Matt Bednar Moffitt Cancer Center Nainesh Parikh Navya Care OncoDaily Oncology Patrick Hwu Randa Perkins Roderick Harris Shaffer Smit Patel Stephen Konya Xavier Avat

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage